Previous research has revealed that the Apolipoprotein-ε4 (APOE-ε4) allele increases the risk for a variety of diseases in aging populations, specifically Alzheimer’s and cardiovascular disease. And yet, despite the negative effects of this genetic variant, it remains prevalent in approximately 20% of the human population.
Breaking: Lykos Therapeutics Moved to Patent MDMA In Late 2022, Filing Reveals – Psychedelic Alpha
While obtaining a patent on the drug itself might be tricky—Merck had patented MDMA over a hundred years ago in 1912 after it found it
June 14, 2024